225
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Campylobacter concisus is prevalent in the gastrointestinal tract of patients with microscopic colitis

ORCID Icon, ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 924-930 | Received 05 May 2020, Accepted 02 Jul 2020, Published online: 15 Jul 2020

References

  • Miehlke S, Verhaegh B, Tontini GE, et al. Microscopic colitis: pathophysiology and clinical management. Lancet Gastroenterol Hepatol. 2019;4(4):305–314.
  • Chetty R, Govender D. Lymphocytic and collagenous colitis: an overview of so-called microscopic colitis. Nat Rev Gastroenterol Hepatol. 2012;9(4):209–218.
  • Nyhlin N, Wickbom A, Montgomery SM, et al. Long-term prognosis of clinical symptoms and health-related quality of life in microscopic colitis: a case-control study. Aliment Pharmacol Ther. 2014;39(9):963–972.
  • Tong J, Zheng Q, Zhang C, et al. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110(2):265–276.
  • Bonderup OK, Wigh T, Nielsen GL, et al. The epidemiology of microscopic colitis: a 10-year pathology-based nationwide Danish cohort study. Scand J Gastroenterol. 2015;50(4):393–398.
  • Lophaven SN, Lynge E, Burisch J. The incidence of inflammatory bowel disease in Denmark 1980–2013: a nationwide cohort study. Aliment Pharmacol Ther. 2017;45(7):961–972.
  • Jaruvongvanich V, Poonsombudlert K, Ungprasert P. Smoking and risk of microscopic colitis: a systematic review and meta-analysis. Inflamm Bowel Dis. 2019;25(4):672–678.
  • Bonderup OK, Nielsen GL, Dall M, et al. Significant association between the use of different proton pump inhibitors and microscopic colitis: a nationwide Danish case-control study. Aliment Pharmacol Ther. 2018;48(6):618–625.
  • Burke KE, Ananthakrishnan AN, Lochhead P, et al. Identification of menopausal and reproductive risk factors for microscopic colitis-results from the nurses’ health study. Gastroenterology. 2018;155(6):1764–1775.
  • Rindom Krogsgaard L, Kristian Munck L, Bytzer P, et al. An altered composition of the microbiome in microscopic colitis is driven towards the composition in healthy controls by treatment with budesonide. Scand J Gastroenterol. 2019;54(4):446–452.
  • Carstens A, Dicksved J, Nelson R, et al. The gut microbiota in collagenous colitis shares characteristics with inflammatory bowel disease-associated dysbiosis. Clin Transl Gastroenterol. 2019;10(7):e00065.
  • Fischer H, Holst E, Karlsson F, et al. Altered microbiota in microscopic colitis. Gut. 2015;64(7):1185–1186.
  • Kaakoush NO, Castano-Rodriguez N, Mitchell HM, et al. Global epidemiology of Campylobacter infection. Clin Microbiol Rev. 2015;28(3):687–720.
  • Kaakoush NO, Mitchell HM, Man SM. Role of emerging Campylobacter species in inflammatory bowel diseases. Inflamm Bowel Dis. 2014;20(11):2189–2197.
  • Kirk KF, Nielsen HL, Thorlacius-Ussing O, et al. Optimized cultivation of Campylobacter concisus from gut mucosal biopsies in inflammatory bowel disease. Gut Pathog. 2016;8(1):27.
  • Castaño-Rodríguez N, Kaakoush NO, Lee WS, et al. Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut. 2017;66(2):235–215.
  • Nielsen HL, Ejlertsen T, Engberg J, et al. High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study. Clin Microbiol Infect. 2013;19(5):445–450.
  • Mukhopadhya I, Thomson JM, Hansen R, et al. Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis. PLOS One. 2011;6(6):e21490
  • Kirk KF, Meric G, Nielsen HL, et al. Molecular epidemiology and comparative genomics of Campylobacter concisus strains from saliva, faeces and gut mucosal biopsies in inflammatory bowel disease. Sci Rep. 2018;8(1):1902.
  • Mahendran V, Tan YS, Riordan SM, et al. The prevalence and polymorphisms of zonula occluden toxin gene in multiple Campylobacter concisus strains isolated from saliva of patients with inflammatory bowel disease and controls. PLOS One. 2013;8(9):e75525.
  • Gemmell MR, Berry S, Mukhopadhya I, et al. Comparative genomics of Campylobacter concisus: analysis of clinical strains reveals genome diversity and pathogenic potential. Emerg Microbes Infect. 2018;7(1):1–17.
  • Lertpiriyapong K, Gamazon ER, Feng Y, et al. Campylobacter jejuni type VI secretion system: roles in adaptation to deoxycholic acid, host cell adherence, invasion, and in vivo colonization. PLOS One. 2012;7(8):e42842.
  • Nielsen HL, Dalager-Pedersen M, Nielsen H. High risk of microscopic colitis after Campylobacter concisus infection: population-based cohort study. Gut. 2020:1–7.DOI:10.1136/gutjnl-2019-319771
  • Bjerregaard B, Larsen OB. The Danish Pathology Register. Scand J Public Health. 2011;39(7 Suppl):72–74.
  • Hjortswang H, Tysk C, Bohr J, et al. Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis. 2009;15(12):1875–1881.
  • Watt E, Farquarson F, El-Omar E, et al. Development of a q-PCR strategy to detect Campylobacter concisus within biopsy samples [abstract]. Campylobacter, Helicobacter and related Organisms (CHRO). 2013.
  • Bastyns K, Chapelle S, Vandamme P, et al. Specific detection of Campylobacter concisus by PCR amplification of 23S rDNA areas. Mol Cell Probes. 1995;9(4):247–250.
  • Richter M, Rossello-Mora R, Oliver Glockner F, et al. JSpeciesWS: a web server for prokaryotic species circumscription based on pairwise genome comparison. Bioinformatics. 2016;32(6):929–931.
  • Meier-Kolthoff JP, Auch AF, Klenk H-P, et al. Genome sequence-based species delimitation with confidence intervals and improved distance functions. BMC Bioinformatics. 2013;14:60.
  • Kaakoush NO, Deshpande NP, Wilkins MR, et al. The pathogenic potential of Campylobacter concisus strains associated with chronic intestinal diseases. PLOS One. 2011;6(12):e29045.
  • Nielsen HL, Engberg J, Ejlertsen T, et al. Short-term and medium-term clinical outcomes of Campylobacter concisus infection. Clin Microbiol Infect. 2012;18(11):E459–E465.
  • Jarnerot G, Tysk C, Bohr J, et al. Collagenous colitis and fecal stream diversion. Gastroenterology. 1995;109(2):449–455.
  • Kumawat AK, Elgbratt K, Tysk C, et al. Reduced T cell receptor excision circle levels in the colonic mucosa of microscopic colitis patients indicate local proliferation rather than homing of peripheral lymphocytes to the inflamed mucosa. Biomed Res Int. 2013;2013:408638.
  • Imhann F, Bonder MJ, Vich Vila A, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65(5):740–748.
  • Hafiz RA, Wong C, Paynter S, et al. The risk of community-acquired enteric infection in proton pump inhibitor therapy: systematic review and meta-analysis. Ann Pharmacother. 2018;52(7):613–622.
  • Ovesen S, Durack J, Kirk KF, et al. Gut Microbiome Dysbiosis in Microscopic Colitis [abstract]. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). 2018.
  • Kaakoush NO, Castano-Rodriguez N, Day AS, et al. Campylobacter concisus and exotoxin 9 levels in paediatric patients with Crohn's disease and their association with the intestinal microbiota. J Med Microbiol. 2014;63(Pt 1):99–105.
  • Nielsen HL, Nielsen H, Torpdahl M. Multilocus sequence typing of Campylobacter concisus from Danish diarrheic patients. Gut Pathog. 2016;8(1):44.
  • Mahendran V, Liu F, Riordan SM, et al. Examination of the effects of Campylobacter concisus zonula occludens toxin on intestinal epithelial cells and macrophages. Gut Pathog. 2016;8:18.
  • Deshpande NP, Wilkins MR, Castaño-Rodríguez N, et al. Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells. Sci Rep. 2016;6:34288.
  • Nattramilarasu PK, Bücker R, de Sá FDL, et al. Campylobacter concisus impairs sodium absorption in colonic epithelium via ENaC dysfunction and claudin-8 disruption. Int J Mol Sci. 2020;21(2):373.
  • Kaakoush NO, Deshpande NP, Wilkins MR, et al. Comparative analyses of Campylobacter concisus strains reveal the genome of the reference strain BAA-1457 is not representative of the species. Gut Pathog. 2011;3:15.
  • Kirk KF, Tarpgaard I, Méric G, et al. Identifying the Type VI Secretion System in Campylobacter concisus isolates from inflammatory bowel disease patients and healthy controls [abstract]. Campylobacter, Helicobacter and related organisms (CHRO). 2019.
  • Mukhopadhya I, Hansen R, Nicholl CE, et al. A comprehensive evaluation of colonic mucosal isolates of Sutterella wadsworthensis from inflammatory bowel disease. PLOS One. 2011;6(10):e27076.
  • Hiippala K, Kainulainen V, Kalliomaki M, et al. Mucosal prevalence and interactions with the epithelium indicate commensalism of Sutterella spp. Front Microbiol. 2016;7:1706.
  • O'Donovan D, Corcoran GD, Lucey B, et al. Campylobacter ureolyticus: a portrait of the pathogen. Virulence. 2014;5(4):498–506.
  • Macaigne G, Lahmek P, Locher C, et al. Over 90% of cases of Microscopic Colitis can be diagnosed by performing a short colonoscopy. Clin Res Hepatol Gastroenterol. 2017;41(3):333–340.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.